Regeneron Pharmaceuticals, Inc. (BMV:REGN)

Regeneron Pharmaceuticals Statistics

Total Valuation

BMV:REGN has a market cap or net worth of MXN 1.38 trillion. The enterprise value is 1.11 trillion.

Market Cap	1.38T
Enterprise Value	1.11T

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Current Share Class	100.80M
Shares Outstanding	n/a
Shares Change (YoY)	-5.65%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	3.79%
Owned by Institutions (%)	87.76%
Float	98.54M

Valuation Ratios

The trailing PE ratio is 16.97 and the forward PE ratio is 16.19.

PE Ratio	16.97
Forward PE	16.19
PS Ratio	5.33
PB Ratio	2.45
P/TBV Ratio	2.55
P/FCF Ratio	18.73
P/OCF Ratio	15.35
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.10, with an EV/FCF ratio of 15.13.

EV / Earnings	13.70
EV / Sales	4.51
EV / EBITDA	15.10
EV / EBIT	17.47
EV / FCF	15.13

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.11.

Current Ratio	4.13
Quick Ratio	3.28
Debt / Equity	0.11
Debt / EBITDA	0.81
Debt / FCF	0.85
Interest Coverage	84.52

Financial Efficiency

Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 12.42%.

Return on Equity (ROE)	14.87%
Return on Assets (ROA)	5.91%
Return on Invested Capital (ROIC)	12.42%
Return on Capital Employed (ROCE)	10.23%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	16.76M
Profits Per Employee	5.26M
Employee Count	15,410
Asset Turnover	0.37
Inventory Turnover	2.53

Taxes

In the past 12 months, BMV:REGN has paid 13.07 billion in taxes.

Income Tax	13.07B
Effective Tax Rate	13.88%

Stock Price Statistics

The stock price has decreased by -6.51% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.51%
50-Day Moving Average	11,166.65
200-Day Moving Average	14,951.94
Relative Strength Index (RSI)	63.08
Average Volume (20 Days)	310

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.38

Income Statement

In the last 12 months, BMV:REGN had revenue of MXN 258.22 billion and earned 81.10 billion in profits. Earnings per share was 746.77.

Revenue	258.22B
Gross Profit	115.08B
Operating Income	66.65B
Pretax Income	94.17B
Net Income	81.10B
EBITDA	76.44B
EBIT	66.65B
Earnings Per Share (EPS)	746.77

Balance Sheet

The company has 154.92 billion in cash and 62.19 billion in debt, with a net cash position of 277.46 billion.

Cash & Cash Equivalents	154.92B
Total Debt	62.19B
Net Cash	277.46B
Net Cash Per Share	n/a
Equity (Book Value)	562.72B
Book Value Per Share	5,484.64
Working Capital	245.81B

Cash Flow

In the last 12 months, operating cash flow was 89.64 billion and capital expenditures -16.17 billion, giving a free cash flow of 73.46 billion.

Operating Cash Flow	89.64B
Capital Expenditures	-16.17B
Free Cash Flow	73.46B
FCF Per Share	n/a

Margins

Gross margin is 44.57%, with operating and profit margins of 25.81% and 31.41%.

Gross Margin	44.57%
Operating Margin	25.81%
Pretax Margin	36.47%
Profit Margin	31.41%
EBITDA Margin	29.60%
EBIT Margin	25.81%
FCF Margin	28.45%

Dividends & Yields

This stock pays an annual dividend of 67.63, which amounts to a dividend yield of 0.50%.

Dividend Per Share	67.63
Dividend Yield	0.50%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	9.06%
Buyback Yield	5.65%
Shareholder Yield	6.15%
Earnings Yield	5.89%
FCF Yield	5.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:REGN has an Altman Z-Score of 6.51 and a Piotroski F-Score of 4.

Altman Z-Score	6.51
Piotroski F-Score	4